As part of the National Institute of Allergy and Infectious Diseases (NIAID) focus on discovery and development of antivirals against the Covid-19 and one or more identified RNA viruses with pandemic potential, the institute is seeking to establish the Antiviral Drug Discovery (AViDD) program, consisting of several, multidisciplinary centers.
Read more about this news here.
